查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
注意力缺陷多动障碍市场规模、份额和趋势分析报告：按药物类型（兴奋剂、非兴奋剂）、人口统计（儿童、成人）、分销渠道、地区、细分市场预测，2023-2030 年
市场调查报告书
商品编码
1171025

注意力缺陷多动障碍市场规模、份额和趋势分析报告：按药物类型（兴奋剂、非兴奋剂）、人口统计（儿童、成人）、分销渠道、地区、细分市场预测，2023-2030 年

Attention Deficit Hyperactivity Disorder Market Size, Share & Trends Analysis Report By Drug Type (Stimulants, Non-stimulants), By Demographics (Children, Adults), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 114 Pages | 商品交期: 2-10个工作天内

价格

注意力缺陷多动障碍市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球注意力缺陷多动障碍市场预计将达到 186.9 亿美元。从 2023 年到 2030 年，该市场预计将以 4.2% 的复合年增长率增长。用于 ADHD 治疗的强大产品线的存在和随后的批准预计将推动市场增长。后期管线包括Neurocentria, Inc.开发的NRCT-101、Supernus Pharmaceuticals, Inc.的SPN-812和Otsuka America Pharmaceutical, Inc.的EB-1020。

政府机构就 ADHD 的早期诊断和治疗采取的几项举措可能会支持市场的增长。2021 年 1 月，澳大利亚政府将 Vyvanse 纳入药物福利计划（PBS），用于治疗成人多动症。这一纳入使得 Vyvanse 能够为患者提供补贴，使 20,000 多名患者能够以更低的成本从可比的疾病治疗中受益。如果没有 PBS 补贴，患者每年将不得不支付超过 1,200 美元的治疗费用。一旦纳入 PBS，治疗费用为每单位 41.30 美元。预计这些努力也将促进市场的增长。

患者、医生和其他医疗保健专业人员对 ADHD 的认识不断提高可能会增加对诊断和治疗的需求，从而推动注意力缺陷多动障碍市场的增长。注意缺陷多动障碍教练组织 (ACO) 将 10 月定为 ADHD 宣传月，旨在提高人们的认识，为研究和开发筹集资金，并教育人们了解这种疾病。相信这一努力将促进早期诊断并促进产品的吸收。

然而，患有 ADHD 的儿童患其他精神疾病的风险增加，常常使诊断和治疗复杂化。Lundbeck 基金会在 2021 年发表的一项研究发现，患有其他精神障碍的 ADHD 患者更有可能避免服用药物。多动症儿童常见的合併症包括抑郁症、焦虑症、躁郁症、学习障碍、早期语言和交流障碍以及对立任务障碍。

此外，治疗 ADHD 的兴奋剂短缺迫使患者支付昂贵的品牌药物费用，为行为疗法等替代疗法创造空间，对 ADHD 药物治疗的需求产生负面影响。美国缉毒局 (DEA) 等监管机构实施了严格的规定，包括限制 ADHD 药物的生产以避免误用和滥用。需求上升可能导致处方药短缺，从而导致更高的治疗成本并抑制市场增长。因此，药物短缺会阻碍市场增长。

注意力缺陷多动障碍市场报告要点

按药物类型划分，由于对这些药物和症状管理的高需求、政府对使用兴奋剂药物的支持以及正在进行的注意力缺陷多动障碍临床试验，兴奋剂部分将在 2022 年成为市场上最大的部分

根据人口统计数据，由于目标人群庞大且患注意力缺陷多动障碍的风险高，成人细分市场在 2022 年主导了注意力缺陷多动障碍市场。据 ADD Health and Wellness Centers, Inc. 称，这种疾病影响了大约 4-5% 的成年人口

预计 2022 年的注意力缺陷多动障碍市场将在预测期内呈现最快的增长，零售药房领域将占据主导地位。这是由于零售药店中註意力缺陷多动障碍药物的广泛供应以及患者获取的便利性。

由于医疗保健专业人员对可用治疗药物的认识高以及疾病流行率上升等因素，北美在 2022 年主导了全球市场。根据加拿大多动症意识中心 (CADDAC) 的数据，加拿大有超过 150 万人患有这种疾病

由于多动症患病率和治疗需求的增加，预计亚太地区将成为预测期内增长最快的地区。例如，多动症是最常见的神经发育障碍之一，在澳大利亚约有 8.2% 的儿童和 11% 的男孩被确诊。

目录

第一章 调查方法和范围

  • 市场细分和范围
    • 段范围
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库：
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 第一次调查的内容
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法：产品流方法
  • 调查假设
  • 二级信息列表
  • 缩略语表
  • 目的

第二章执行摘要

  • 市场快照
  • 段快照
  • 争用快照

第 3 章註意力缺陷多动障碍：市场变量、趋势和范围

  • 市场系列展望
    • 中枢神经系统药物市场
  • 绘製渗透率和增长前景
  • 监管状况
  • 市场动态
  • 市场驱动力分析
    • 多动症患病率增加
    • 提高医生和患者对多动症的认识
  • 市场约束因素分析
    • 多动症药物短缺
    • 非兴奋剂 ADHD 药物的可用性低
    • 导致儿童漏诊的合併症
  • PESTEL 分析
  • 行业分析——波特五力
  • 管道分析

4. 注意力缺陷多动障碍市场：细分分析，按药物类型，2018-2030 年（百万美元）

  • 注意力缺陷多动障碍市场：药物类型变化分析
  • 兴奋剂系统
    • 苯丙胺
    • □醋甲酯
    • Lisdexamphetamine
    • □醋甲酯
  • 非兴奋剂
    • 托莫西汀
    • 胍法辛
    • 可乐定
    • 其他

5. 注意力缺陷多动障碍市场：细分分析，按人口统计，2018-2030 年（百万美元）

  • 注意力缺陷多动障碍市场：人口统计分析
  • 孩子
  • 成人

6. 注意力缺陷多动障碍市场：细分分析，按分销渠道，2018-2030 年（百万美元）

  • 注意力缺陷/多动障碍市场：分销渠道波动分析
  • 零售药店
  • 医院药房

7. 注意力缺陷多动障碍市场：按地区划分的细分分析，2018-2030 年（百万美元）

  • 区域市场快照
  • 2022 年和 2030 年区域市场份额分析
  • 市场规模、预测以及收入和趋势分析，2022-2030 年
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 西班牙
      • 法国
      • 意大利
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 澳大利亚
      • 韩国
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 多边环境协定
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国

8.注意力缺陷多动障碍市场：竞争分析

  • 主要市场进入者的最新发展和影响分析
    • 协同效应分析：重大交易和战略联盟
      • 新产品发布
      • 併购
      • 许可协议
  • 公司分类
    • 创新者
    • 市场领导者
    • 新兴玩家
    • 热图分析
  • 公司市场分析
  • 供应商情况
    • 主要经销商及渠道合作伙伴名单
    • 潜在最终用户列表
    • 2022 年主要参与者的市场份额分析
    • 消费者行为分析
    • 竞争仪錶盘分析
  • 民营企业
    • 主要初创企业名单
    • 区域网络图
  • 公司简介
    • Pfizer, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 最近的发展
    • Johnson & Johnson Services, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 最近的发展
    • Lupin
      • 公司简介
      • 财务绩效
      • 产品基准
      • 最近的发展
    • Novartis AG
      • 公司简介
      • 财务绩效
      • 产品基准
      • 最近的发展
    • Takeda Pharmaceutical Company Limited
      • 公司简介
      • Shire
      • 财务绩效
      • 产品基准
      • 最近的发展
    • Mallinckrodt plc.
      • 公司简介
      • 财务绩效
      • 产品基准
    • Purdue Pharma Lp
      • 公司简介
      • 产品基准
    • NEOS Therapeutics, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 最近的发展
    • Supernus Pharmaceuticals, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 最近的发展
Product Code: GVR-2-68038-795-7

Attention Deficit Hyperactivity Disorder Market Growth & Trends:

The global attention deficit hyperactivity disorder market size is expected to reach USD 18.69 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.2% from 2023 to 2030. The presence of a strong product pipeline for the treatment of ADHD and their subsequent approval is expected to boost the market growth. Some late-stage pipeline products are NRCT-101 developed by Neurocentria, Inc., SPN-812 by Supernus Pharmaceuticals, Inc., and EB-1020 by Otsuka America Pharmaceutical, Inc.

Several initiatives undertaken by government bodies regarding early diagnosis and treatment of ADHD are likely to support the market growth. In January 2021, the Australian Government included Vyvanse under its Pharmaceutical Benefits Scheme (PBS) for the treatment of adult patients with ADHD. This inclusion makes the availability of Vyvanse at a subsidized rate to patients and more than 20,000 patients received a comparable treatment for the disease at low cost and benefits. Without PBS subsidy, the patients had to pay more than USD 1,200 per person annually for their treatment. After the inclusion in PBS, they will receive the treatment at USD 41.30 per script. Such initiatives are also expected to drive market growth.

Increasing awareness about ADHD among patients, physicians, and other healthcare providers may increase the demand for diagnosis and treatment which in turn propel the growth of the attention deficit hyperactivity disorder market. The Attention Deficit Hyperactivity Disorder Coaches Organization (ACO) celebrates October as the ADHD awareness month intending to raise awareness, generate funding for R&D, and educate people about disorders. This initiative may boost early diagnosis, thereby, increasing product penetration.

However, the risk of comorbidity with other psychiatric disorders is high among children with ADHD, often making diagnosis and treatment of the disorder complex. A research study published by the Lundbeck Foundation in 2021 showed that ADHD patients with other psychiatric comorbid conditions were more likely to avoid taking medicines. Some of the comorbid conditions that typically occur in ADHD pediatric patients are depression, anxiety, bipolar disorder, learning disorder, early speech/communication problems, and oppositional defiant disorder.

Furthermore, the shortage of stimulants to treat ADHD has forced patients to pay for expensive branded medication and create scope for substitute therapies, such as behavioral therapy, which will negatively impact the demand for ADHD pharmacological therapies. Strict regulations are implemented by regulatory bodies, such as the U.S. Drug Enforcement Administration (DEA), which limit the production of ADHD drugs to avoid misuse or abuse. Amid an increase in demand, this can create a shortage of medical products, consequently increasing the cost of treatments and restraining market growth. Thus, the shortage of medicines may impede the market growth.

Attention Deficit Hyperactivity Disorder Market Report Highlights:

  • By drug type, the stimulants segment accounted for the largest share of the market in 2022 due to the high demand for these medicines and the management of symptoms, government support for the use of stimulants drugs, and continuing clinical trials regarding attention deficit hyperactive disorder
  • Based on demographics, the adults segment dominated the attention-deficit hyperactivity disorder market in 2022 owing to the large target population base and high risk of developing the attention-deficit hyperactive disorder. According to ADD Health and Wellness Centers, Inc. the disorder affects approximately 4-5% of the adult population
  • Retail pharmacy segment dominated the attention-deficit hyperactivity disorder market in 2022 and is anticipated to witness the fastest growth over the forecast period. This can be attributed to the wide availability of attention deficit hyperactivity disorder drugs at retail pharmacies and their ease of accessibility to patients
  • North America dominated the global market in 2022 owing to factors such as high awareness among healthcare professionals about drugs available for treatment and the rise in disease prevalence. According to the Center for ADHD Awareness Canada (CADDAC), more than 1.5 million people are affected by the disease in Canada
  • Asia Pacific is expected to be the fastest-growing region during the forecast period to increasing ADHD prevalence and treatment demand in the region. For instance, ADHD is one of the most common neurodevelopment diseases with approximately 8.2% of children and 11% of boys diagnosed in Australia

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation and Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Snapshot

Chapter 3 Attention Deficit Hyperactivity Disorder: Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Central Nervous System Therapeutics Market
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Regulatory Landscape
  • 3.4 Market Dynamics
  • 3.5 Market Driver Analysis
    • 3.5.1 Increasing Prevalence of ADHD
    • 3.5.2 Increasing Awareness About ADHD Among Physicians and Patients
  • 3.6 Market Restraint Analysis
    • 3.6.1 Shortage of ADHD Drugs
    • 3.6.2 Low Availability of Non-stimulant ADHD Drugs
    • 3.6.3 Comorbidities Leading to Underdiagnosis in Children
  • 3.7 PESTEL Analysis
  • 3.8 Industry Analysis - Porter's Five Forces
  • 3.9 Pipeline Analysis

Chapter 4 Attention Deficit Hyperactivity Disorder Market: Segment Analysis, by Drug Type, 2018 - 2030 (USD Million)

  • 4.1 Attention Deficit Hyperactivity Disorder Market: Drug Type Movement Analysis
  • 4.2 Stimulants
    • 4.2.1 Stimulants Market, 2018 - 2030 (USD Million)
    • 4.2.2 Amphetamine
      • 4.2.2.1 Amphetamine Market, 2018 - 2030 (USD Million)
    • 4.2.3 Methylphenidate
      • 4.2.3.1 Methylphenidate Market, 2018 - 2030 (USD Million)
    • 4.2.4 Lisdexamfetamine
      • 4.2.4.1 Lisdexamfetamine Market, 2018 - 2030 (USD Million)
    • 4.2.5 Dexmethylphenidate
      • 4.2.5.1 Dexmethylphenidate Market, 2018 - 2030 (USD Million)
  • 4.3 Non - Stimulants
    • 4.3.1 Non - stimulants Market, 2018 - 2030 (USD Million)
    • 4.3.2 Atomoxetine
      • 4.3.2.1 Atomoxetine Market, 2018 - 2030 (USD Million)
    • 4.3.3 Guanfacine
      • 4.3.3.1 Guanfacine Market, 2018 - 2030 (USD Million)
    • 4.3.4 Clonidine
      • 4.3.4.1 Clonidine Market, 2018 - 2030 (USD Million)
    • 4.3.5 Others
      • 4.3.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Attention Deficit Hyperactivity Disorder Market: Segment Analysis, by Demographic, 2018 - 2030 (USD Million)

  • 5.1 Attention Deficit Hyperactivity Disorder Market: Demographics Movement Analysis
  • 5.2 Children
    • 5.2.1 Children Market, 2018 - 2030 (USD Million)
  • 5.3 Adults
    • 5.3.1 Adult Market, 2018 - 2030 (USD Million)

Chapter 6 Attention Deficit Hyperactivity Disorder Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

  • 6.1 Attention Deficit Hyperactivity Disorder Market: Distribution Channel Movement Analysis
  • 6.2 Retail Pharmacy
    • 6.2.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.3 Hospital Pharmacy
    • 6.3.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)

Chapter 7 Attention Deficit Hyperactivity Disorder Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 7.1 Regional Market Snapshot
  • 7.2 Regional Market Share Analysis, 2022 & 2030
  • 7.3 Market Size, Forecasts, and Revenue & Trend Analysis, 2022 to 2030
    • 7.3.1 North America
      • 7.3.1.1 North America Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.1.2 U.S.
      • 7.3.1.2.1 U.S. Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.1.3 Canada
      • 7.3.1.3.1 Canada Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.2 Europe
      • 7.3.2.1 Europe Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.2 UK
      • 7.3.2.2.1 UK Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.3 Germany
      • 7.3.2.3.1 Germany Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.4 Spain
      • 7.3.2.4.1 Spain Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.5 France
      • 7.3.2.5.1 France Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.6 Italy
      • 7.3.2.6.1 Italy Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.3 Asia Pacific
      • 7.3.3.1 Asia Pacific Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.2 Japan
      • 7.3.3.2.1 Japan Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.3 China
      • 7.3.3.3.1 China Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.4 India
      • 7.3.3.4.1 India Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.5 Australia
      • 7.3.3.5.1 Australia Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.6 South Korea
      • 7.3.3.6.1 South Korea Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.4 Latin America
      • 7.3.4.1 Latin America Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.4.2 Brazil
      • 7.3.4.2.1 Brazil Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.4.3 Mexico
      • 7.3.4.3.1 Mexico Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.4.4 Argentina
      • 7.3.4.4.1 Argentina Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.5 MEA
      • 7.3.5.1 MEA Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.5.2 South Africa
      • 7.3.5.2.1 South Africa Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.5.3 Saudi Arabia
      • 7.3.5.3.1 Saudi Arabia Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.5.4 UAE
      • 7.3.5.4.1 UAE Attention Deficit Hyperactivity Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)

Chapter 8 Attention Deficit Hyperactivity Disorder Market: Competitive Analysis

  • 8.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 8.1.1 Synergy Analysis: Major Deals and Strategic Alliances
      • 8.1.1.1 New Product Launches
      • 8.1.1.2 Mergers and Acquisitions
      • 8.1.1.3 Licensing Agreements
  • 8.2 Company Categorization
    • 8.2.1 Innovators
    • 8.2.2 Market Leaders
    • 8.2.3 Emerging Players
    • 8.2.4 Heat Map Analysis
  • 8.3 Company Market Position Analysis
  • 8.4 Vendor Landscape
    • 8.4.1 List of Key Distributors and Channel Partners
    • 8.4.2 List of Potential End-Users
    • 8.4.3 Key Company Market Share Analysis, 2022
    • 8.4.4 Consumer Behavior Analysis
    • 8.4.5 Competitive Dashboard Analysis
  • 8.5 Private Companies
    • 8.5.1 List of Key Emerging Companies
    • 8.5.2 Regional Network Map
  • 8.6 Company Profiles
    • 8.6.1 Pfizer, Inc.
      • 8.6.1.1 Company Overview
      • 8.6.1.2 Financial Performance
      • 8.6.1.3 Product Benchmarking
      • 8.6.1.4 Recent Developments
    • 8.6.2 Johnson & Johnson Services, Inc.
      • 8.6.2.1 Company Overview
      • 8.6.2.2 Financial Performance
      • 8.6.2.3 Product Benchmarking
      • 8.6.2.4 Recent Developments
    • 8.6.3 Lupin
      • 8.6.3.1 Company Overview
      • 8.6.3.2 Financial Performance
      • 8.6.3.3 Product Benchmarking
      • 8.6.3.4 Recent Developments
    • 8.6.4 Novartis AG
      • 8.6.4.1 Company Overview
      • 8.6.4.2 Financial Performance
      • 8.6.4.3 Product Benchmarking
      • 8.6.4.4 Recent Developments
    • 8.6.5 Takeda Pharmaceutical Company Limited
      • 8.6.5.1 Company Overview
      • 8.6.5.2 Shire plc
      • 8.6.5.3 Financial Performance
      • 8.6.5.4 Product Benchmarking
      • 8.6.5.5 Recent Developments
    • 8.6.6 Mallinckrodt plc.
      • 8.6.6.1 Company Overview
      • 8.6.6.2 Financial Performance
      • 8.6.6.3 Product Benchmarking
    • 8.6.7 Purdue Pharma L.p.
      • 8.6.7.1 Company Overview
      • 8.6.7.2 Product Benchmarking
    • 8.6.8 NEOS Therapeutics, Inc.
      • 8.6.8.1 Company Overview
      • 8.6.8.2 Financial performance
      • 8.6.8.3 Product Benchmarking
      • 8.6.8.4 Recent Developments
    • 8.6.9 Supernus Pharmaceuticals, Inc.
      • 8.6.9.1 Company Overview
      • 8.6.9.2 Financial performance
      • 8.6.9.3 Product Benchmarking
      • 8.6.9.4 Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 FDA-approved Amphetamine Drugs for ADHD
  • Table 5 5 FDA-approved Methylphenidate Drugs for ADHD
  • Table 6 FDA-Approved Non-Stimulants Drugs for ADHD
  • Table 7 Wholesale Prices of Prescription ADHD Medications
  • Table 8 List of Parameters
  • Table 9 List of Distributors
  • Table 10 Global Attention Deficit Hyperactivity Disorder Market, By Region, 2018 - 2030 (USD Million)
  • Table 11 Global Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 12 Global Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 13 Global Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 North America Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
  • Table 15 North America Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 16 North America Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 17 North America Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 18 U.S. Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 19 U.S. Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 20 U.S. Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 21 Canada Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 22 Canada Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 23 Canada Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 24 Europe Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
  • Table 25 Europe Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 26 Europe Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 27 Europe Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28 Germany Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 29 Germany Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 30 Germany Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 UK Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 32 UK Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 33 UK Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 France Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 35 France Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 36 France Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Italy Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 38 Italy Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 39 Italy Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40 Spain Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 41 Spain Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 42 Spain Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Japan Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 48 Japan Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 49 Japan Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 China Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 51 China Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 52 China Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 India Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 54 India Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 55 India Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 South Korea Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 57 South Korea Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 58 South Korea Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 Australia Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 60 Australia Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 61 Australia Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Latin America Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
  • Table 63 Latin America Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 64 Latin America Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 65 Latin America Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Brazil Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 67 Brazil Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 68 Brazil Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Mexico Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 70 Mexico Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 71 Mexico Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 Argentina Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 73 Argentina Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 74 Argentina Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa Attention Deficit Hyperactivity Disorder Market, By Country, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 77 Middle East & Africa Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 78 Middle East & Africa Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 South Africa Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 83 South Africa Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 84 South Africa Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 85 UAE Attention Deficit Hyperactivity Disorder Market, By Demographics, 2018 - 2030 (USD Million)
  • Table 86 UAE Attention Deficit Hyperactivity Disorder Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 87 UAE Attention Deficit Hyperactivity Disorder Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Attention Deficit Hyperactivity Disorder (ADHD) Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Commodity Flow Approach
  • Fig. 10 Market Snapshot (2022) (USD Million)
  • Fig. 11 Segment Snapshot (2022) (USD Million)
  • Fig. 12 Competitive Snapshot
  • Fig. 13 Penetration & Growth Prospect Mapping
  • Fig. 14 ADHD Market Driver Impact
  • Fig. 15 ADHD Market Restraint Impact
  • Fig. 16 PESTEL Analysis
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 Attention Deficit Hyperactivity Disorder (ADHD) Drug Type Outlook: Key Takeaways
  • Fig. 19 Attention Deficit Hyperactivity Disorder Market: Drug Type Movement Analysis (USD Million)
  • Fig. 20 Stimulants Market 2018 - 2030 (USD Million)
  • Fig. 21 Amphetamine Market, 2018 - 2030 (USD Million)
  • Fig. 22 Methylphenidate Market, 2018 - 2030 (USD Million)
  • Fig. 23 Lisdexamfetamine Market, 2018 - 2030 (USD Million)
  • Fig. 24 Dexmethylphenidate Market, 2018 - 2030 (USD Million)
  • Fig. 25 Non - stimulants Market, 2018 - 2030 (USD Million)
  • Fig. 26 Atomoxetine Market, 2018 - 2030 (USD Million)
  • Fig. 27 Guanfacine Market, 2018 - 2030 (USD Million)
  • Fig. 28 Clonidine Market, 2018 - 2030 (USD Million)
  • Fig. 29 Others Market, 2018 - 2030 (USD Million)
  • Fig. 30 Attention Deficit Hyperactivity Disorder Demographic Outlook: Key Takeaways
  • Fig. 31 Attention Deficit Hyperactivity Disorder Market: Demographic Movement Analysis (USD Million)
  • Fig. 32 Children (2 - 17 years) Market, 2018 - 2030 (USD Million)
  • Fig. 33 Adult Market, 2018 - 2030 (USD Million)
  • Fig. 34 Attention Deficit Hyperactivity Disorder Distribution Channel Outlook: Key Takeaways
  • Fig. 35 Attention Deficit Hyperactivity Disorder Market: Distribution Channel Analysis (USD Million)
  • Fig. 36 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 37 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Snapshot, 2022 & 2030
  • Fig. 39 Regional Market Place: Key takeaways
  • Fig. 40 North America
  • Fig. 41 North America Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD million)
  • Fig. 42 U.S.
  • Fig. 43 U.S. Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada
  • Fig. 45 Canada Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD million)
  • Fig. 46 Europe
  • Fig. 47 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 48 U.K.
  • Fig. 49 U.K. Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany
  • Fig. 51 Germany Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 52 Spain
  • Fig. 53 Spain Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 54 France
  • Fig. 55 France Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 56 Italy
  • Fig. 57 Italy Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific
  • Fig. 59 Asia Pacific Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 60 Japan
  • Fig. 61 Japan Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 62 China
  • Fig. 63 China Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 64 India
  • Fig. 65 India Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 66 Australia
  • Fig. 67 Australia Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea
  • Fig. 69 South Korea Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 70 Latin America
  • Fig. 71 Latin America Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 72 Brazil
  • Fig. 73 Brazil Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 74 Mexico
  • Fig. 75 Mexico Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina
  • Fig. 77 Argentina Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 78 Middle East & Africa
  • Fig. 79 MEA Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 80 South Africa
  • Fig. 81 South Africa Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 82 Saudi Arabia
  • Fig. 83 Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 84 UAE
  • Fig. 85 UAE Attention Deficit Hyperactivity Disorder (ADHD) Market, 2018 - 2030 (USD Million)
  • Fig. 86 Heat Map Analysis
  • Fig. 87 Company Market Position Analysis, 2022
  • Fig. 88 Company Market Position Analysis, 2022
  • Fig. 89 Company Market Share Analysis (2022)
  • Fig. 90 Consumer Behavior Analysis
  • Fig. 91 Market Differentiators